617 Tisotumab vedotin shows immunomodulatory activity through induction of immunogenic cell death

• Elizabeth Gray,
• Jeffrey Harris,
• Celine Jacquemont,
• Kelly Hensley,
• Sean Allred,
• Esther Trueblood,
• John Gosink,
• Robert Thurman,
• Kaleb Smith,
• Mark Bieda,
• Jason Gow,
• Lauren Brady,
• Ibrahima Soumaoro,
• Shweta Jain,
• Leonardo Nicacio

Affiliations

Elizabeth Gray

Nuffield Department of Clinical Neurosciences, Oxford University, Oxford, UK

Jeffrey Harris

Aff1 Celgene Cellular Therapeutics Warren NJ USA

Celine Jacquemont

Aff5 Phenopath Seattle WA USA

Kelly Hensley

1Seattle Genetics, Inc., Bothell, USA

Sean Allred

1Seattle Genetics, Inc., Bothell, USA

Esther Trueblood

1Seattle Genetics, Inc., Bothell, USA

John Gosink

1Seattle Genetics, Inc., Bothell, USA

Robert Thurman

1Seattle Genetics, Inc., Bothell, USA

Kaleb Smith

1Seattle Genetics, Inc., Bothell, USA

Mark Bieda

1Seattle Genetics, Inc., Bothell, USA

Jason Gow

1Seattle Genetics, Inc., Bothell, USA

Lauren Brady

2Genmab US, Inc., Princeton, NJ, USA

Ibrahima Soumaoro

2Genmab US, Inc., Princeton, NJ, USA

Shweta Jain

1Seattle Genetics, Inc., Bothell, USA

Leonardo Nicacio

1Seattle Genetics, Inc., Bothell, USA